Comments
Loading...
Nektar Therapeutics (NKTR) Forecast
NewsEarningsNektar Therapeutics (NKTR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestNektar Therapeutics (NASDAQ:NKTR) Stock Quotes, Forecast and News Summary
Nektar Therapeutics Stock (NASDAQ: NKTR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Nektar Therapeutics (NKTR) stock?
You can purchase shares of Nektar Therapeutics (NASDAQ:NKTR) through any online brokerage.
Who are Nektar Therapeutics (NKTR) competitors?
Other companies in Nektar Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Xeris Biopharma Holdings (NASDAQ:XERS), Aquestive Therapeutics (NASDAQ:AQST), Telomir Pharmaceuticals (NASDAQ:TELO) and SIGA Technologies (NASDAQ:SIGA).
What is the forecast, or price target, for Nektar Therapeutics (NKTR) stock?
Nektar Therapeutics has a consensus price target of $4.22.
What is the current price for Nektar Therapeutics (NKTR)?
The stock price for Nektar Therapeutics (NASDAQ: NKTR) is $0.9975 last updated November 21, 2024 at 9:29 AM EST.
Does Nektar Therapeutics (NKTR) pay a dividend?
There are no upcoming dividends for Nektar Therapeutics.
When is Nektar Therapeutics (NASDAQ:NKTR) reporting earnings?
Nektar Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Nektar Therapeutics (NKTR) going to split?
There is no upcoming split for Nektar Therapeutics.
What sector and industry does Nektar Therapeutics (NKTR) operate in?
Nektar Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.